✦ LIBER ✦

Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2- d ]pyrimidines and Pyrimido[5,4- b ]- and -[4,5- b ]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase

✍ Scribed by Showalter, H. D. Hollis; Bridges, Alexander J.; Zhou, Hairong; Sercel, Anthony D.; McMichael, Amy; Fry, David W.

Book ID: 118258756
Publisher: American Chemical Society
Year: 1999
Tongue: English
Weight: 315 KB
Volume: 42
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm9903949

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase.

✍ H. D. Hollis Showalter; Alexander J. Bridges; Hairong Zhou; Anthony D. Sercel; A 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

Tyrosine Kinase Inhibitors. 12. Synthesi

Tyrosine Kinase Inhibitors. 12. Synthesis and Structure−Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor

✍ Rewcastle, Gordon W.; Bridges, Alexander J.; Fry, David W.; Rubin, J. Ronald; De 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 203 KB

Tyrosine Kinase Inhibitors. 18. 6-Substi

Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4- d ]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor

✍ Smaill, Jeff B.; Showalter, H. D. Hollis; Zhou, Hairong; Bridges, Alexander J.; 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 160 KB

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d]pyrimidines as Inhibitors of Receptor Tyrosine Kinases (RTK)

✍ Andreas Martin-Kohler; Jörg Widmer; Guido Bold; Thomas Meyer; Urs Séquin; Peter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 German ⚖ 276 KB 👁 1 views

## Abstract Receptor tyrosine kinases such as VEGFR2 (vascular endothelial growth factor receptor 2, KDR) or EGFR (epidermal growth factor receptor) play crucial roles in a variety of diseases, such as cancer. Recently, some pyrrolopyrimidines were shown to be potent EGFR inhibitors. Therefore, new

Tyrosine kinase inhibitors. 5. Synthesis

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.

✍ Rewcastle, Gordon W.; Denny, William A.; Bridges, Alexander J.; Zhou, Hairong; C 📂 Article 📅 1995 🏛 American Chemical Society 🌐 English ⚖ 756 KB

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 5. Synthesis and Structure-Activity Relationships for 4-((Phenylmethyl)amino)- and 4-(Phenylamino) quinazolines as Potent Adenosine 5′-Triphosphate Binding Site Inhibitors of the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor.

✍ G. W. REWCASTLE; W. A. DENNY; A. J. BRIDGES; H. ZHOU; D. R. CODY; A. MCMICHAEL; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB